| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Data Driven Strategy and Case Study for Implementation of Singlicate Analysis in Ligand Binding Assays Used for PK Quantitation
|
Qu, Qiang
|
|
|
26 |
5 |
|
artikel
|
| 2 |
An Investigation of In Vitro Anti-Cancer Efficacy of Dihydroartemisinin-Loaded Bovine Milk Exosomes Against Triple-Negative Breast Cancer
|
Kumar, Dulla Naveen
|
|
|
26 |
5 |
|
artikel
|
| 3 |
A Perspective on Evaluating Life Stage Differences in Drug Dosages for Drug Labeling and Instructions
|
Gu, Tianshu
|
|
|
26 |
5 |
|
artikel
|
| 4 |
A Risk-Based Assessment for Determining the Pharmacokinetic Comparability Requirements of Biologic-Device Combination Products Administered by Subcutaneous Injection
|
Nøhr, Mark Klitgaard
|
|
|
26 |
5 |
|
artikel
|
| 5 |
Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker Assessment
|
Azadeh, Mitra
|
|
|
26 |
5 |
|
artikel
|
| 6 |
Blood–Brain Barrier Permeability is Affected by Changes in Tight Junction Protein Expression at High-Altitude Hypoxic Conditions—this may have Implications for Brain Drug Transport
|
Liu, Guiqin
|
|
|
26 |
5 |
|
artikel
|
| 7 |
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
|
Jani, Darshana
|
|
|
26 |
5 |
|
artikel
|
| 8 |
Design of Auto-Adaptive Drug Delivery System for Effective Delivery of Peptide Drugs to Overcoming Mucus and Epithelial Barriers
|
Ding, Ruihuan
|
|
|
26 |
5 |
|
artikel
|
| 9 |
Evaluating the Performance of Two Automated Anti-drug Antibodies Assays for Infliximab and Adalimumab Without Acid Dissociation
|
Karsten, Carley
|
|
|
26 |
5 |
|
artikel
|
| 10 |
Evaluation of the Generic Drug User Fee Act (GDUFA) Program for Fiscal Years 2013–2022
|
Friedman, Erica L.
|
|
|
26 |
5 |
|
artikel
|
| 11 |
ICH M10 Bioanalytical Method Validation Guideline-1 year Later
|
Vazvaei-Smith, Faye
|
|
|
26 |
5 |
|
artikel
|
| 12 |
Letter to the Editor on “Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies”
|
Sun, Wanjie
|
|
|
26 |
5 |
|
artikel
|
| 13 |
Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro
|
Lee, David
|
|
|
26 |
5 |
|
artikel
|
| 14 |
Mass Balance in Pharmaceutical Stress Testing: A Review of Principles and Practical Applications
|
Marden, Stacey
|
|
|
26 |
5 |
|
artikel
|
| 15 |
Modeling Metformin and Dapagliflozin Pharmacokinetics in Chronic Kidney Disease
|
Shahidehpour, Andrew
|
|
|
26 |
5 |
|
artikel
|
| 16 |
Non-Invasive, Continuous, Quantitative Detection of Solvent Content in Vacuum Tray Drying
|
Louge, Michel Y.
|
|
|
26 |
5 |
|
artikel
|
| 17 |
Predicting Tumor Volume Doubling Time and Progression-Free Survival in Untreated Patients from Patient-Derived-Xenograft (PDX) Models: A Translational Model-Based Approach
|
Tosca, E. M.
|
|
|
26 |
5 |
|
artikel
|
| 18 |
Recommendations for Development and Validation of a Fit-For-Purpose Biomarker Assays Using Western Blotting; An-AAPS Sponsored Initiative to Harmonize Industry Practices
|
Kinhikar, Arvind
|
|
|
26 |
5 |
|
artikel
|
| 19 |
The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2
|
Khalid, Kanwal
|
|
|
26 |
5 |
|
artikel
|
Tijdschrift beschrijving